Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 24 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

25%

6 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (8)
P 1 (1)
P 2 (3)
P 3 (3)
P 4 (3)

Trial Status

Completed15
Unknown4
Recruiting3
Active Not Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT04567771Not ApplicableRecruiting

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

NCT03828994Not ApplicableActive Not RecruitingPrimary

Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II

NCT03994055Not ApplicableCompleted

Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer

NCT06756568Active Not RecruitingPrimary

The Diagnostic Utility of Ultrasound in Pelvic Inflammatory Disease (PID)

NCT06360965Not ApplicableRecruitingPrimary

Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain

NCT05408624Recruiting

Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses

NCT00783419CompletedPrimary

Rate of Pelvic Inflammatory Disease at St. Michael's Hospital

NCT04723069Phase 2CompletedPrimary

Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases

NCT05648747UnknownPrimary

Pelvic Inflammatory Disease in COVID-19 Era

NCT04234945Not ApplicableUnknown

Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity

NCT03054402Phase 1CompletedPrimary

First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845

NCT01160640Phase 2CompletedPrimary

The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)

NCT03391440Phase 4UnknownPrimary

A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease

NCT01793584Not ApplicableCompleted

Surgical Success After Laparoscopic vs Abdominal Hysterectomy

NCT01671280Completed

Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)

NCT02972151Phase 2UnknownPrimary

Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae

NCT01236131CompletedPrimary

The Role of Novel Organisms in Acute Endometritis

NCT00115388Not ApplicableCompletedPrimary

Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease

NCT01299259Not ApplicableCompletedPrimary

Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease

NCT00683865Phase 3CompletedPrimary

Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.

Scroll to load more

Research Network

Activity Timeline